The TH-1 Graves' Disease panel is a targeted diagnostic tool used in the evaluation and management of Graves' disease, an autoimmune disorder that is the most common cause of hyperthyroidism. This panel includes three fundamental tests: T3 Free, T4 Free, and Thyroid Stimulating Hormone (TSH), each providing critical insights into thyroid gland function and its regulatory mechanisms.

 The TH-2 Graves' Disease panel is an advanced diagnostic array specifically tailored for the comprehensive evaluation of Graves' disease, an autoimmune disorder that often leads to hyperthyroidism. This panel encompasses a wide range of tests that assess not only thyroid function but also potential systemic impacts and related health concerns.

 The TH-3 Graves' Disease panel is an extensive diagnostic tool specifically designed for evaluating Graves' disease, an autoimmune disorder that often leads to hyperthyroidism. This panel combines thyroid function tests with assessments for autoimmune markers, metabolic health, and nutritional status to provide a comprehensive overview of the disease's impact on the body.

 The TH-4 Graves' Disease panel is a sophisticated and comprehensive set of diagnostic tests specifically designed to assess Graves' disease, an autoimmune disorder leading to hyperthyroidism. This panel not only evaluates thyroid hormone levels and autoimmune markers but also examines the broader systemic effects of the disease on metabolic health, nutritional status, and potential comorbid conditions.

The TSH Receptor Binding Antibody (TRAb) Test detects autoantibodies that bind to thyroid-stimulating hormone receptors, often causing hyperthyroidism and Graves’ disease. Elevated results may confirm Graves’ or help distinguish it from other thyroid disorders. Doctors order this test for patients with weight loss, rapid heartbeat, or eye problems. Results provide critical insight into autoimmune thyroid disease, treatment monitoring, and relapse risk assessment.

 The TH-4 Hyperthyroidism panel is an exhaustive diagnostic array designed to evaluate hyperthyroidism comprehensively, with a particular focus on autoimmune thyroid diseases such as Graves' disease. It encompasses a broad spectrum of tests that assess thyroid function, autoimmune markers, metabolic health, and nutritional status, providing a holistic view of the patient's condition.

The Thyroid Stimulating Immunoglobulin (TSI) Test detects antibodies that stimulate the thyroid gland, often causing hyperthyroidism and Graves’ disease. High TSI levels may lead to symptoms such as weight loss, rapid heartbeat, or eye problems. Doctors order this test to confirm Graves’ disease, monitor treatment, or assess relapse risk. Results provide essential insight into autoimmune thyroid disorders and guide personalized management strategies.

The TH-1 Hyperthyroidism panel is designed to evaluate the thyroid gland's function, specifically focusing on conditions associated with an overactive thyroid, such as hyperthyroidism. This panel includes three critical tests: T3 Free, T4 Free, and Thyroid Stimulating Hormone (TSH), each providing valuable insights into thyroid health and its systemic effects.

 The TH-2 Hyperthyroidism panel is a comprehensive diagnostic tool designed to assess the function of the thyroid gland and identify conditions leading to hyperthyroidism. It goes beyond basic thyroid hormone assessments to include a wide range of tests that evaluate the overall health and potential complications associated with hyperthyroidism.

 The TH-3 Hyperthyroidism panel is a detailed diagnostic tool designed to assess the function of the thyroid gland in the context of hyperthyroidism. It includes a broad spectrum of tests that evaluate not only thyroid hormones and antibodies but also the impact of hyperthyroidism on various bodily functions, including metabolism, blood health, and nutritional status.

The TPO Antibody Endpoint Test measures thyroid peroxidase antibodies, which target the enzyme needed for thyroid hormone production. Elevated levels often indicate autoimmune thyroid disorders such as Hashimoto’s thyroiditis or Graves’ disease. Doctors use this test to confirm thyroid autoimmunity, investigate symptoms like fatigue or weight changes, and guide treatment planning for hypothyroidism, hyperthyroidism, or other thyroid-related conditions.

 The FT3, FT4, RT3, TPO and Thyroglobulin Ab Panel is a comprehensive diagnostic tool designed to evaluate thyroid function and identify autoimmune thyroid diseases. This panel includes tests that measure thyroid hormone levels, assess the conversion of these hormones, and detect antibodies that may indicate an autoimmune response against the thyroid gland. By providing a detailed overview of thyroid health, this panel helps healthcare providers diagnose and manage various thyroid-related conditions effectively.

The Thyroid Peroxidase and Thyroglobulin Antibodies Test measures TPO and TgAb antibodies that target thyroid enzymes and proteins essential for hormone production. High levels are linked to autoimmune thyroid disorders such as Hashimoto’s thyroiditis and Graves’ disease. Doctors order this test to evaluate fatigue, weight changes, neck swelling, or irregular heartbeat and to confirm thyroid autoimmunity. It provides vital insight into thyroid function and endocrine health.